Adjunctive Transcranial Direct Current Stimulation
Stopped early · Not applicable · Has a placebo group
Conditions studied: Chronic Pain, Psychiatric Disorders
In brief
Transcranial direct current stimulation (tDCS) is an investigational device that has not been approved for the treatment of any medical condition by the FDA but is allowed to be used for research purposes. In clinical trials tDCS has been associated with pain relief by decreasing the intensity and duration of chronic pain. tDCS potentially works by stimulating the brain by delivering an extremely low-level electrical current to areas below the forehead - areas associated with chronic pain. It is anticipated that this current will increase brain activity or the likelihood of brain activity in these areas, affecting individual's ability to regulate pain. The purpose of this study is to compare eligible participants in the Pain Management Program at The Menninger Clinic receiving adjunctive real transcranial Direct Current Stimulation (tDCS) versus those receiving sham tDCS in the resolution of chronic pain. The primary objectives are: (1) improving pain tolerance and (2) improving subjective pain experience. Secondary objectives are: (1) improving subjective experience of sleep quality and (2) increasing physical activity.
Key facts
- Study ID
- NCT02665988
- Run by
- Baylor College of Medicine
- People needed
- 4
- Starts
- 2016-01-01
- Expected to finish
- 2018-01-01
- Last updated by the study team
- 2021-04-15
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Males and females greater than equal to 18 years old.
- Females with a confirmed negative pregnancy test (which is conducted within 24 hours of admission to the hospital as part of standard of clinical care).
- Confirmed diagnosis of chronic pain.
- Must be admitted to the Pain Management Program at The Menninger Clinic.
You may not qualify if…
- Presence of actively psychosis, cognitively impairment.
- Contraindications to tDCS:
- Presence of any preexisting irritation, cuts, or lesions where the tDCS will be placed (i.e., the forehead).
- Presence of any preexisting unstable medical conditions, or conditions that may increase the risk of stimulation such as uncontrolled epilepsy.
- Presence of history of severe cranial trauma with alteration of the cranial anatomy or metallic intracranial implants.
- None fluent in the English language.
- Presence of known sensitivity to Lidocaine 4%.
Where it is running
- The Pain Management Program at The Menninger Clinic — Houston, Texas, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.